Cite
Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice
MLA
Joleen M. Hubbard, et al. “Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice.” Journal of the National Comprehensive Cancer Network, vol. 13, Sept. 2015, pp. 1097–101. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c9cd9ed3bc58446952246c0748cd480&authtype=sso&custid=ns315887.
APA
Joleen M. Hubbard, Andreas S. Beutler, Kathryn J. Ruddy, Charles L. Loprinzi, Deirdre R. Pachman, Nilay Shah, Axel Grothey, & Lindsey R. Sangaralingham. (2015). Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice. Journal of the National Comprehensive Cancer Network, 13, 1097–1101.
Chicago
Joleen M. Hubbard, Andreas S. Beutler, Kathryn J. Ruddy, Charles L. Loprinzi, Deirdre R. Pachman, Nilay Shah, Axel Grothey, and Lindsey R. Sangaralingham. 2015. “Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice.” Journal of the National Comprehensive Cancer Network 13 (September): 1097–1101. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c9cd9ed3bc58446952246c0748cd480&authtype=sso&custid=ns315887.